Veterinary medicines: regulatory information
This section of the website provides information on the regulation of medicines for veterinary use in the European Union (EU). It particularly concerns the centralised procedure, where the European Medicines Agency (EMA) plays a key role.
The navigation menu contains three main sections corresponding to the key medicinal product lifecycle stages:
- research and development, including maximum residue limits (MRLs);
- marketing authorisation;
Each main section provides an overview on a landing page, with sub-topics in the sub-menu in alphabetical order.
For further information on EU legislation and procedures for the regulation of veterinary medicines, see volumes 4-9 of the rules governing medicinal products in the EU.
United Kingdom’s (UK) withdrawal from the EU
EMA has published important information to help users of the centralised procedure prepare for the expected consequences of 'Brexit', including their obligations related to establishment within the European Economic Area (EEA). For more information, see UK’s withdrawal from the EU.